Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
14.7M
-
Shares change
-
+879K
-
Total reported value, excl. options
-
$3.39B
-
Value change
-
+$195M
-
Put/Call ratio
-
0.88
-
Number of buys
-
120
-
Number of sells
-
-102
-
Price
-
$231.00
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q2 2023
287 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q2 2023.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.7M shares
of 22.2M outstanding shares and own 66.09% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (1.55M shares), Avoro Capital Advisors LLC (1.52M shares), JANUS HENDERSON GROUP PLC (1.48M shares), VANGUARD GROUP INC (1.47M shares), BlackRock Inc. (1.04M shares), STATE STREET CORP (544K shares), Assenagon Asset Management S.A. (467K shares), MARSHALL WACE, LLP (461K shares), ALLIANCEBERNSTEIN L.P. (371K shares), and PAULSON & CO. INC. (350K shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.